Optimal glycemic control with insulin detemir and aspart improves lipoprotein composition and particle number/size in poorly controlled T2DM

被引：0
|
作者：
Kumar, Pratima
Wang, Shaoyun
Balas, Bogdana
Darland, Celia
Walz, Barbara
Johnson, Lisa
Mathew, Manoj
Cusi, Kenneth
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A254 / A255
页数：2
相关论文
共 50 条
  • [41] Telemedicine-supported lifestyle intervention for glycemic control in patients with CHD and T2DM: multicenter, randomized controlled trial
    Mueller, Stephan
    Dinges, Sophia M. T.
    Gass, Felix
    Fegers-Wustrow, Isabel
    Treitschke, Julian
    von Korn, Pia
    Boscheri, Alessandra
    Krotz, Janosch
    Freigang, Felix
    Dubois, Clara
    Winzer, Ephraim B.
    Linke, Axel
    Edelmann, Frank
    Feuerstein, Anna
    Wolfram, Oliver
    Schaefer, Kerstin
    Verket, Marlo
    Wolfarth, Bernd
    Doerr, Marcus
    Wachter, Rolf
    Hackenberg, Bjoern
    Rust, Sarah
    Nebling, Thomas
    Amelung, Volker
    Halle, Martin
    NATURE MEDICINE, 2025, : 1203 - 1213
  • [42] Use of Structured SMBG Facilitates Earlier Initiation of Insulin Therapy in Poorly Controlled T2DM Patients: Results from the STeP Study
    Wegmann, Nathan
    Jelsovsky, Zhihong
    Rees, Christen
    Wagner, Robin
    DIABETES, 2011, 60 : A314 - A314
  • [43] AGE OF DIABETES ONSET: GLYCEMIC CONTROL AND HYPOGLYCEMIA BENEFIT WITH NEW INSULIN GLARGINE 300U/ML IN T2DM
    Twigg, S.
    Khunti, K.
    Forst, T.
    Janez, A.
    Merino-Trigo, A.
    Stella, P.
    Grisoni, M. L.
    Galstyan, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A45 - A45
  • [44] Effect of pioglitazone on vascular reactivity is associated with improved insulin resistance and lipid metabolism, but not glycemic control, in Mexican Americans with T2DM
    Wajcberg, Estela
    Fernandez, Marianella
    Defronzo, Ralph A.
    Cersosimo, Eugenio
    DIABETES, 2006, 55 : A145 - A146
  • [45] Effects of exenatide versus insulin glargine on body composition in overweight and obese T2DM patients: a randomized controlled trial
    Yin, Ting-Ting
    Bi, Yan
    Li, Ping
    Shen, Shan-Mei
    Wang, Wei-Min
    Jiang, Can
    Gao, Cai-Xia
    Wang, Yan
    Gao, Li-Jun
    Zhu, Da-Long
    Feng, Wen-Huan
    NUTRITION & METABOLISM, 2018, 15
  • [46] Physical Exercise Methods and Their Effects on Glycemic Control and Body Composition in Adults with Type 2 Diabetes Mellitus (T2DM): A Systematic Review
    Flores, Bastian Parada
    Luna-Villouta, Pablo
    Salazar, Cristian Martinez
    Valderrama, Jorge Flandez
    Contreras, Luis Valenzuela
    Flores-Rivera, Carol
    Vargas-Vitoria, Rodrigo
    EUROPEAN JOURNAL OF INVESTIGATION IN HEALTH PSYCHOLOGY AND EDUCATION, 2023, 13 (11) : 2529 - 2545
  • [47] Effects of exenatide versus insulin glargine on body composition in overweight and obese T2DM patients: a randomized controlled trial
    Ting-Ting Yin
    Yan Bi
    Ping Li
    Shan-Mei Shen
    Wei-Min Wang
    Can Jiang
    Cai-Xia Gao
    Yan Wang
    Li-Jun Gao
    Da-Long Zhu
    Wen-Huan Feng
    Nutrition & Metabolism, 15
  • [48] Superior prandial glucose control with insulin aspart compared to regular human insulin in basal bolus therapy with NPH in patients with inadequately controlled T1DM or T2 DM
    Gao, Yan
    Pan, Changyu
    Zou, Dajin
    Xu, Zhangrong
    Liu, Xiaomin
    Guo, Xiaohui
    DIABETES, 2006, 55 : A464 - A464
  • [49] Empagliflozin as Add-On to Metformin Plus Sulfonylurea (SU) for 24 Weeks Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)
    Haering, Hans-Ulrich
    Merker, Ludwig
    Seewaldt-Becker, Elke
    Weimer, Marc
    Meinicke, Thomas
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES, 2013, 62 : A279 - A279
  • [50] Insulin secretion predicts the response to therapy with exenatide plus pioglitazone, but not to basal/bolus insulin in poorly controlled T2DM patients: Results from the Qatar study
    Abdul-Ghani, Muhammad
    Migahid, Osama
    Megahed, Ayman
    Singh, Rajvir
    Kamal, Dalia
    DeFronzo, Ralph A.
    Jayyousi, Amin
    DIABETES OBESITY & METABOLISM, 2018, 20 (04): : 1075 - 1079
12345